Shandong Wohua Pharmaceutical Co., Ltd. (002107.SZ)
CNY 5.22
(-0.57%)
CNY 5.22
(-0.57%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 129.24 Million | 185.25 Million | 200.11 Million | 196.57 Million | 31.65 Million | 107.88 Million |
| Net Income | 58.76 Million | 89.88 Million | 161.32 Million | 186.32 Million | 97.24 Million | 39.99 Million |
| Depreciation & Amortization | 33.22 Million | 35.32 Million | 33.04 Million | 28.16 Million | 18.57 Million | 18.89 Million |
| Deferred income taxes | 701.29 Thousand | 2.17 Million | 1.33 Million | 2.21 Million | 2.5 Million | -2.89 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 47.59 Million | 54.89 Million | -14.04 Million | -21.07 Million | -90.2 Million | 41.29 Million |
| Other non-cash items | 7.81 Million | 5.14 Million | 19.79 Million | 3.16 Million | 6.03 Million | 7.69 Million |
| Investing Cash Flow | -2.62 Million | -5.6 Million | -19.07 Million | 24.73 Million | -35.16 Million | -62.22 Million |
| Investments in PPE | -2.71 Million | -6.76 Million | -19.07 Million | -54.17 Million | -32.22 Million | -63.09 Million |
| Acquisitions | 93.28 Thousand | 1.16 Million | - | 77.66 Million | 62.45 Thousand | 1.03 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 93.28 Thousand | 1.16 Million | -19.07 Million | 1.23 Million | -3 Million | 869.71 Thousand |
| Financing Cash Flow | -3.55 Million | -229.32 Million | -343.69 Million | -32.95 Million | -18.66 Million | -27.78 Million |
| Debt repayment | -613.59 Thousand | -277.4 Thousand | -188.83 Million | -70 Million | - | - |
| Dividends payments | - | -150.07 Million | -150.07 Million | -43.29 Million | -18.66 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -3.55 Million | -78.97 Million | -188.83 Million | 84.83 Million | - | -27.78 Million |
| Accounts receivables | 50.32 Million | -40.84 Million | 63.27 Million | -34.45 Million | -78.82 Million | 21.9 Million |
| Accounts payables | 2.62 Million | 78.07 Million | -24.82 Million | 33.47 Million | -2.03 Million | 50.37 Million |
| Inventory | -5.35 Million | 15.48 Million | -53.82 Million | -22.3 Million | -11.85 Million | -28.09 Million |
| Other working capital | 3.33 Million | 2.17 Million | 1.33 Million | 2.21 Million | 2.5 Million | 69.38 Million |
| Cash at beginning of period | 278.28 Million | 326.21 Million | 488.86 Million | 300.51 Million | 322.74 Million | 304.87 Million |
| Cash at end of period | 401.1 Million | 276.54 Million | 326.21 Million | 488.86 Million | 300.51 Million | 322.74 Million |
| Capital Expenditure | -2.71 Million | -6.76 Million | -19.07 Million | -54.17 Million | -32.22 Million | -63.09 Million |
| Effect of forex changes on cash | -260.29 Thousand | 0.05 | 0.17 | -16.65 Thousand | -53.22 Thousand | - |
| Net cash flow / Change in cash | 122.81 Million | -49.66 Million | -162.64 Million | 188.34 Million | -22.23 Million | 17.87 Million |
| Free Cash Flow | 126.53 Million | 178.49 Million | 181.04 Million | 142.4 Million | -573.31 Thousand | 44.78 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.41 Million | 9.66 Million | 58.76 Million | 1.36 Million | 20.19 Million | 11.75 Million |
| Depreciation & Amortization | 8.2 Million | 8.2 Million | 33.22 Million | 8.24 Million | -16.72 Million | 8.36 Million |
| Deferred income taxes | - | - | 701.29 Thousand | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 41.14 Million | - | 47.59 Million | 44.96 Million | -5.72 Million | 5.72 Million |
| Other non-cash items | 6.88 Million | 44.82 Million | 7.81 Million | -17.2 Million | 38.2 Million | -1.12 Million |
| Investing Cash Flow | -2.17 Million | -119.48 Thousand | -2.62 Million | -559.71 Thousand | -794.13 Thousand | -678.88 Thousand |
| Investments in PPE | -2.35 Million | -119.48 Thousand | -2.71 Million | -614.19 Thousand | -795.93 Thousand | -678.88 Thousand |
| Acquisitions | 3924.00 | - | 93.28 Thousand | 54.48 Thousand | 1800.00 | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 169.76 Thousand | - | 93.28 Thousand | 54.48 Thousand | 1800.00 | - |
| Financing Cash Flow | -144.55 Million | - | -3.55 Million | -96.95 Thousand | -3.13 Million | -325.32 Thousand |
| Debt repayment | - | - | -613.59 Thousand | - | - | - |
| Dividends payments | -144.3 Million | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -255.08 Thousand | - | -3.55 Million | -96.95 Thousand | -3.13 Million | -325.32 Thousand |
| Accounts receivables | 25.29 Million | - | 50.32 Million | 50.32 Million | -14.53 Million | 14.53 Million |
| Accounts payables | - | - | 2.62 Million | - | - | - |
| Inventory | 15.84 Million | - | -5.35 Million | -5.35 Million | 8.8 Million | -8.8 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 456.68 Million | 401.1 Million | 278.28 Million | 364.05 Million | 330.87 Million | 307.63 Million |
| Cash at end of period | 314.98 Million | 456.68 Million | 401.1 Million | 401.1 Million | 362.9 Million | 330.87 Million |
| Capital Expenditure | -2.35 Million | -119.48 Thousand | -2.71 Million | -614.19 Thousand | -795.93 Thousand | -678.88 Thousand |
| Effect of forex changes on cash | - | - | -260.29 Thousand | 326.65 Thousand | 0.78 | -471.56 Thousand |
| Net cash flow / Change in cash | -141.7 Million | 55.58 Million | 122.81 Million | 37.04 Million | 32.02 Million | 23.24 Million |
| Free Cash Flow | -2.25 Million | 54.36 Million | 126.53 Million | 36.75 Million | 35.15 Million | 24.03 Million |
VCISF
002777
BOC
002218
DJCO
PALAF